Beiersdorf H1 2026: NIVEA's Turnaround Gets a More Expensive Phase Two

Beiersdorf's Q1 2026 results already carried a NIVEA turnaround plan — phase one. Six months later, NIVEA sales are still down 6.8% for the half, and the company has just announced phase two: an incremental EUR 100 million of consumer-facing marketing spend in the second half of the year, on top of whatever phase one was already spending. The clearest read of that sequence is not "Beiersdorf is investing in NIVEA." It is that the first attempt did not work well enough on its own, and this is a bigger, more expensive one.

What actually declined

Group net sales fell 3.5% organically in the first half, with the Consumer segment — the NIVEA-containing division — down 4.0%. The industrial tesa adhesives segment, by contrast, held up far better, down just 0.9% for the half and actually growing 2.5% in the second quarter alone. Group EBIT margin excluding special factors came in at 15.5% for the half. Shares fell as much as 7.95% in the hour after the report crossed.

Why a second phase, and what it costs

The company cut its full-year margin guidance to reflect the additional spending: Consumer segment EBIT margin is now guided to at least 11.0%, down from 13.6% a year earlier, and the Group figure to at least 11.8%, down from 14.0%. That is a real, quantified cost — Beiersdorf is explicitly trading near-term profitability for a second attempt at reigniting NIVEA's growth, targeting a return to growth in 2027 rather than claiming success now. A company confident its first-phase fixes were working would not need to guide margins down further to fund a second round of the same kind of spending.

What to watch

NIVEA's own quarterly sales trend from here is the number that matters — whether the decline narrows toward flat over the next two quarters as the extra marketing spend lands, which would validate phase two, or whether it persists near the current mid-single-digit pace despite the incremental EUR 100 million, which would raise the same question about phase three.